---
inFeed: true
hasPage: true
inNav: false
inLanguage: null
keywords: []
description: >-
  Over the years, our focus on quality science has allowed us to attract and
  retain some of the most experienced clinical and medical research experts in
  our industry. Our passion for quality and the world-class talent it attracts
  leads to the impressive range of therapeutic experience we offer.
datePublished: '2016-07-14T19:37:12.241Z'
dateModified: '2016-07-14T19:36:56.815Z'
title: Therapeutic Expertise
author: []
authors: []
publisher: null
starred: false
sourcePath: _posts/2016-07-14-therapeutic-expertise.md
url: therapeutic-expertise/index.html
_type: Article

---
# Therapeutic Expertise

### Broad therapeutic area experience produces quality clinical trial management

Over the years, our focus on quality science has allowed us to attract and retain some of the most experienced clinical and medical research experts in our industry. Our passion for quality and the world-class talent it attracts leads to the impressive range of therapeutic experience we offer.

## Central Nervous System (CNS)
![](https://the-grid-user-content.s3-us-west-2.amazonaws.com/61c90144-8f71-4e55-877a-d9d13d3d94f1.png)

Rho has conducted over 200 CNS studies with more than 3,000 sites and 70,000 subjects. These studies cover the full range of drug development and include full service multi-protocol programs as well as tailored services for smaller projects.

## Analgesia
![](https://the-grid-user-content.s3-us-west-2.amazonaws.com/e90566bc-50cb-448a-903f-decf9d9f5d1f.png)

Clinical trials in pain indications present unique challenges. Subjects drop out of pain trials for reasons including insufficient pain relief, treatment side effects, burden of multiple study visits and assessments and use of rescue medication. Rho has extensive experience addressing these challenges to set your program up for success.

## Psychiatric Disorders
![](https://the-grid-user-content.s3-us-west-2.amazonaws.com/dfce9895-2bd5-4a5b-9769-d4612babcfd3.png)

Rho has participated in 50+ psychiatric disorder studies to date and our staff has over 125 total years' experience with psychiatric disorders, including a psychiatrist on staff with 30+ years clinical research experience.

## Dental
![](https://the-grid-user-content.s3-us-west-2.amazonaws.com/d260270d-bd44-487f-a555-6769eee1ea3f.png)

Our extensive experience conducting dental clinical trials includes over 50 dental studies working with more than 250 sites and enrolling more than 25,000 subjects.

## Attention Deficit Hyperactivity Disorder (ADHD)
![](https://the-grid-user-content.s3-us-west-2.amazonaws.com/b5736675-7126-4d35-81cd-1efb319c3c62.png)

Rho has participated in more than a dozen ADHD studies including 5 in the past 3 years. Our collaboration with Sponsors has included total program development; protocol development/design; study management and execution (all services); FDA interaction; Type B meeting support, attendance, and briefing package authorship and preparation; and assistance with and filing NDA submissions.

## Respiratory
![](https://the-grid-user-content.s3-us-west-2.amazonaws.com/94663528-366b-4e22-90ad-0ad6127c4811.png)

Rho has conducted 90 studies with more than 800 sites and including nearly 20,000 subjects. Rho has experience with a broad range of respiratory indications.

## Ophthalmology
![](https://the-grid-user-content.s3-us-west-2.amazonaws.com/29554051-3964-4d49-b509-88f2e7a53ecc.png)

Rho has conducted over 50 studies with more than 600 sites and 10,000 subjects. These studies cover the full range of drug development and include multi-protocol programs with several of the premier ophthalmology companies in the market as well as tailored services for virtual biotech and start-up companies.

## Hematology
![](https://the-grid-user-content.s3-us-west-2.amazonaws.com/1737dc53-7517-4aec-b161-61782bc423b0.png)

Rho has conducted 50+ hematology clinical studies and trials involving \>15,000 subjects at more than 1,300 sites in over 30 countries. We have conducted industry- sponsored, government-funded, and investigator initiated research.